By the University of Manchester’s estimates, $2.4 billion has been invested in graphene research. In 2014, Lux Research projected a 2025 global market of $349 million for the material; however, in 2013, sales of graphene totaled only $12 million. Manufacture of the material has accelerated, with total production capacity of graphene nanoplatelets in the Americas; […]
Major US equity markets contracted roughly 2.0% or more on June 29 when Greece failed to reach an agreement with its international creditors. As a result, the country essentially defaulted on its $1.7 billion loan payment to the International Monetary Fund (IMF) the following day. While discussions are expected to continue, Greece no longer has […]
Productivity growth for instrument and laboratory product companies decelerated in fiscal year 2014 (FY14) due to the negative currency impact on revenue growth for most US companies, varied market demand and increased investments in personnel. With half of the companies recording productivity gains, the average sales-per-employee ratio for the 20 companies in the table on […]
In May, the NSF’s National Center for Science and Engineering Statistics published an InfoBrief with its figures on federal funding for R&D for fiscal 2012–14 (FY12–14). The data were collected from February to August of 2014 from the “NSF Survey of Federal Funds for Research and Development: FYs 2013–15,” which was sent to federal agencies. […]
Expanding Markets Lift Affymetrix Q1 Sales Affymetrix first quarter sales grew 6.9%, 9% excluding currency, to $88.7 million. The negative impact from currency was partially reduced by hedging gains of $2.2 million. Product sales grew 7.7% to $79.4 million. Consumables sales grew 9.4%, and Instruments sales fell 23.5% to account for 86% and 3% of […]
Bad Timing for Agilent Agilent Technologies fiscal second quarter sales ending April 30 contracted 2.5% to $963 million due to stronger-than-expected currency headwinds and divested product lines. In addition, timing of orders and shipping delays from the new Americas logistics center negatively impacted revenue growth by $30 million, or 3.0% of revenue growth. In spite […]
Sales for the IBO Analytical Instrument Index, which is comprised primarily of broad-based global analytical instrument businesses, declined 2.2% to $3,578 million. Excluding currency headwinds of 4.4%, Index sales grew 2.2%, driven by sales of LC and LC/MS, as well as demand from pharmaceutical and biopharma customers for Agilent and Waters. Demand for materials characterization […]
First quarter IBO Life Science Index sales advanced 6.3%, 7.1% excluding currency to $3,110 million, primarily due to Il-lumina’s strong sequencing revenues. Excluding Illumina, Index sales grew 2.7% or 2.8% on a currency-neutral basis. Overall, pharmaceutical and biopharma sales were strong for a majority of companies in the Index, especially for bioprouction within Thermo’s Life […]
First quarter US GDP was revised from an increase of 0.2% to a contraction of 0.7%. This divergence was attributed to a greater-than-expected trade imbalance as well as lower inventory growth and consumer spending. While early estimates suggest a rebound in second quarter GDP growth in the 3% range, weak consumer spending may constrain such […]
Growth for major publicly held instrument and laboratory product businesses stalled in the calendar year first quarter due to glaring currency headwinds and delayed government spending in Japan. For the seven US businesses whose financial results are profiled on page 9, sales contracted 1.8%, as currency and divestments reduced growth by 6.9% and 0.5%, respectively. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
